Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02643381 · ClinicalTrials.gov registry record · Phase 4
Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical Trial
A Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 801
- Enrollment target
NCT02643381 is a Phase 4 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 801 participants.
The verdict
NCT02643381, a Phase 4 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 801 participants
- Enrollment target
Study Summary
Patients who are having problems breathing sometimes require placement of a breathing tube in their mouth and windpipe. The purpose of this breathing tube is to save the patient's life. It is common to give the patient a medication to sedate him or her before the breathing tube is placed. For patients who are gravely ill two medications are commonly used: etomidate or ketamine. Both medications have risks and benefits. Researchers at UT-Southwestern Medical Center and Parkland Memorial Hospital would like to do a study to figure out which one is better for our patients.
Interventions
- DRUG Ketamine
- DRUG Etomidate
- PROCEDURE Emergency Endotracheal Intubation
- DEVICE Mechanical Ventilation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 801 participants |
| Start Date | 2016-06-06 |
| Est. Completion | 2020-12-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02643381
The ClinicalTrials.gov registry entry for NCT02643381 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 801 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Ketamine is the first listed.
NCT02643381 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02643381 about?
NCT02643381 is a clinical study titled "Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical Trial". Patients who are having problems breathing sometimes require placement of a breathing tube in their mouth and windpipe. The purpose of this breathing tube is to save the patient's life. It is common to give the patient a medication to sedate him or her before the breathing tube is placed. For patien...
What is the current status of trial NCT02643381?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 801 participants. The study started on 2016-06-06. Estimated completion is 2020-12-01.
What interventions are being tested in trial NCT02643381?
The interventions under investigation include: Ketamine (DRUG), Etomidate (DRUG), Emergency Endotracheal Intubation (PROCEDURE), Mechanical Ventilation (DEVICE).
Who is sponsoring clinical trial NCT02643381?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.